1 Khenchouche A,Sadouki N,Boudriche A,et al.Human papilloma virus and Epstein-barr virus co-infection in cervical carcinoma in algerian women[J].Virol J,2013,10(1):340-347. 2 Injumpa N,Suprasert P,Srisomboon J,et al.Limited value of vaginal cytology in detecting recurrent disease after radical hysterectomy for early stage cervical carcinoma[J].Asian Pac J Cancer Prev,2006,7(4):656-658. 3 Lajin B,Alachkar A.The NQO1 polymorphism C609T(Pro187Ser)and cancer susceptibility:a comprehensive meta-analysis[J].Br J Cancer,2013,109(5):1325-1337. 4 Lin L,Piao J,Gao W,et al.DEK over expression as an independent biomarker for poor prognosis in colorectal cancer[J].BMC Cancer,2013,13:366-374. 5 Siegel D,Franklin WA,Ross D.Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors[J].Clin Cancer Res,1998,4(9):2065-2070. 6 Garate M,Wani AA,Li G.The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells[J].Free Radic Biol Med,2010,48(12):1601-1609. 7 De Flora S,Bennicelli C,D′Agostini F,et al.Cytosolic activation of aromatic and heterocyclic amines.Inhibition by dicoumarol and enhancement in viral hepatitis B[J].Environ Health Perspect,1994,102(Suppl 6):69-74. 8 Zhao Y,Lin H,Shen D,et al.Distribution of HPV genotypes in uterine cervical lesions in Yanbian,northern China[J].Pathol Int,2008,58(10):643-647. 9 Siegel D,Ross D.Immunodetection of NAD(P)H:quinone oxidoreductase 1(NQO1)in human tissues[J].Free Radic Biol Med,2000,29(3/4):246-253. 10 Nair S,Xu C,Shen G,et al.Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole(BHA)in the small intestine and liver of Nrf2 knockout and C57BL/6J mice[J].Pharm Res 2006,23(11):2621-2637. 11 Schulz WA,Krummeck A,Rsinger I,et al.Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies[J].Pharmacogenetics,1997,7(3):235-239. 12 Soucek P,Susova S,Mohelnikova-Duchonova B,et al.Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe[J].Neoplasma,2010,57(5):415-421. 13 Lin L,Qin Y,Jin T,et al.Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma[J].Exp Mol Pathol,2014,96(2):200-205. 14 Ahn KS,Sethi G,Jain AK,et al.Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB,IkappaBalpha kinase,c-Jun N-terminal kinase,Akt,p38,and p44/42 mitogen-activated protein kinases and potentiates apoptosis[J].J Biol Chem,2006,281(29):19798-19808. 15 Garate M,Wani AA,Li G.The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells[J].Free Radic Biol Med,2010,48(12):1601-1609. |